SCHEMBL20016473

SCHEMBL20016473

CCC(=O)C(CCC(=O)NC(CCC(=O)NC(CCC(=O)C(CC)CSS)C(=O)C(C)C)C(=O)C(C)C)NC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24119914 0.83 NOD1 (0.35) —
SCHEMBL23790945 0.80 NOD1 (0.31) —
SCHEMBL24119971 0.80 NOD1 (0.35) —
SCHEMBL21902130 0.78 NOD1 (0.34) —
SCHEMBL22857315 0.76 NOD1 (0.41) —
SCHEMBL16248525 0.75 NOD1 (0.36) —
SCHEMBL16248526 0.75 NOD1 (0.36) —
SCHEMBL24119913 0.74 NOD1 (0.35) —
SCHEMBL19871861 0.73 NOD1 (0.37) —
SCHEMBL23136493 0.72 NOD1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9932581-B2 Compositions and methods for modulating apolipoprotein C-III expression IONIS PHARMACEUTICALS, INC. (US) 2018-04-03 — — US disclosed
Send feedback